CLINICAL_TRIALS
trial_result
· 2022-08-29
Clinical Trial Update: Abatacept in Juvenile Dermatomyositis [Phase 4]
Summary
Phase 4 clinical trial evaluating abatacept in juvenile dermatomyositis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: George Washington University | Conditions: Dermatomyositis | Phase 4 | Status: COMPLETED | Results posted: 2022-08-29